Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06910631

Optimizing the Care Pathway of Febrile Children Via Capillary C-reactive Protein Assay in Primary Care

Optimisation du Parcours de Soins Des Enfants fébriles Par l'Utilisation de la CRP Capillaire en Soins Primaires : Protocole d'un Essai Multicentrique randomisé

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
420 (estimated)
Sponsor
Centre Hospitalier Universitaire de Nīmes · Academic / Other
Sex
All
Age
3 Months – 15 Years
Healthy volunteers
Not accepted

Summary

Fever is the leading reason for outpatient consultations among children aged 2 to 9 years. The main concern in fever is severe bacterial infection, particularly for younger children. History and clinical examination do not always differentiate viral infections from bacterial infection. In 20% of febrile children, no infectious focus is found after examination and additional tests are necessary. The first one is measuring C-reactive protein (CRP). The results are obtained in several hours on an outpatient basis, causing long delays before starting treatment and often requiring telephone calls or further consultations. Emergency room use is constantly increasing, generating growing tensions within healthcare facilities, yet a large number of visits are avoidable. Among children visiting the pediatric emergency room, parents reported being referred by their primary care physician in approximately 20% of cases for children aged 1 to 5 years and in 30% of cases for children under one year old. The use of capillary medical device to measure CRP in primary care could reduce this referral rate and help relieve overcrowding in emergency rooms, as well as unscheduled consultation centers and medical analysis laboratories. This would result in a streamlined care pathway, saving time for both physicians and patients, as well as reducing the cost of care for the healthcare system.

Conditions

Interventions

TypeNameDescription
OTHERCapillary CRPCRP measured semi-quantitatively using ACTIM-CRP device

Timeline

Start date
2025-09-15
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2025-04-04
Last updated
2025-11-19

Locations

16 sites across 1 country: France

Source: ClinicalTrials.gov record NCT06910631. Inclusion in this directory is not an endorsement.